Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice

Neuroscience Letters

Volumn 470, Issue 1, 2010, Pages 33-37

  Pamplona, Fabrício A ^a   Menezes de Lima Jr , Octávio ^b   Takahashi, Reinaldo N ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

15 Epi lipoxin A4; Anandamide; Aspirin triggered lipoxin; Endocannabinoid; Lipoxygenase

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ACETYLSALICYLIC ACID; ANANDAMIDE; BOC 2; CANNABINOID 1 RECEPTOR; CYCLOOXYGENASE 2; ENDOCANNABINOID; LIPOXIN A; RECEPTOR BLOCKING AGENT; RIMONABANT; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG POTENTIATION; ENZYME INHIBITION; EXPERIMENTAL STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACIDS; ASPIRIN; CATALEPSY; CENTRAL NERVOUS SYSTEM AGENTS; CYCLOOXYGENASE INHIBITORS; LIPOXINS; MALE; MICE; MODELS, NEUROLOGICAL; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, LIPOXIN;

EID: 74149084561     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.050     Document Type: Article

References (28)

1. Bisogno T., Ligresti A., and Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 81 (2005) 224-238
2. Brink C., Dahlen S.E., Drazen J., Evans J.F., Hay D.W., Nicosia S., Serhan C.N., Shimizu T., and Yokomizo T. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55 (2003) 195-227
3. Chiang N., Serhan C.N., Dahlen S.E., Drazen J.M., Hay D.W., Rovati G.E., Shimizu T., Yokomizo T., and Brink C. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58 (2006) 463-487
4. Cristino L., Starowicz K., De Petrocellis L., Morishita J., Ueda N., Guglielmotti V., and Di Marzo V. Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. Neuroscience 151 (2008) 955-968
5. Dzitoyeva S., Imbesi M., Uz T., Dimitrijevic N., Manev H., and Manev R. Caffeic acid attenuates the decrease of cortical BDNF transcript IV mRNA induced by swim stress in wild-type but not in 5-lipoxygenase-deficient mice. J. Neural Transm. 115 (2008) 823-827
6. Fox A., Kesingland A., Gentry C., McNair K., Patel S., Urban L., and James I. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92 (2001) 91-100
7. Fride E., Perchuk A., Hall F.S., Uhl G.R., and Onaivi E.S. Behavioral methods in cannabinoid research. Methods Mol. Med. 123 (2006) 269-290
8. Guhring H., Hamza M., Sergejeva M., Ates M., Kotalla C.E., Ledent C., and Brune K. A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur. J. Pharmacol. 454 (2002) 153-163
9. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., and Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6155-6160
10. Kim J., and Alger B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7 (2004) 697-698
11. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods 16 (1986) 355-357
12. McMahon B., Mitchell S., Brady H.R., and Godson C. Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22 (2001) 391-395
13. 4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. Prostaglandins Other Lipid Mediat. 80 (2006) 123-135
14. Pertwee R.G. The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br. J. Pharmacol. 46 (1972) 753-763
15. Prediger R.D., Franco J.L., Pandolfo P., Medeiros R., Duarte F.S., Di Giunta G., Figueiredo C.P., Farina M., Calixto J.B., Takahashi R.N., and Dafre A.L. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: evidence for a dissociation between cognitive deficits and the glutathione system response. Behav. Brain Res. 177 (2007) 205-213
16. Prediger R.D., Medeiros R., Pandolfo P., Duarte F.S., Passos G.F., Pesquero J.B., Campos M.M., Calixto J.B., and Takahashi R.N. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 151 (2008) 631-643
17. Rall J.M., Mach S.A., and Dash P.K. Intrahippocampal infusion of a cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res. 968 (2003) 273-276
18. 1. Neuropharmacology 49 (2005) 660-668
19. Souza M.H.L.P., Menezes-de-Lima Jr. O., Zamuner S.R., Fiorucci S., and Wallace J.L. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G54-61
20. Takahashi R.N., Pamplona F.A., and Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci. Lett. 380 (2005) 270-275
21. Teather L.A., Packard M.G., and Bazan N.G. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn. Mem. 9 (2002) 41-47
22. Uz T., Dimitrijevic N., Imbesi M., Manev H., and Manev R. Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci. Lett. 436 (2008) 269-272
23. Uz T., Dimitrijevic N., Tueting P., and Manev H. 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor. Neurol. Neurosci. 20 (2002) 15-20
24. Uz T., Dwivedi Y., Qeli A., Peters-Golden M., Pandey G., and Manev H. Glucocorticoid receptors are required for up-regulation of neuronal 5-lipoxygenase (5LOX) expression by dexamethasone. FASEB J. 15 (2001) 1792-1794
25. Yates M.L., and Barker E.L. Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. Mol. Pharmacol. 76 (2009) 11-17
26. Yildirim E., Zhang Z., Uz T., Chen C.Q., Manev R., and Manev H. Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci. Lett. 345 (2003) 141-143
27. Yu M., Ives D., and Ramesha C.S. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272 (1997) 21181-21186
28. 4. FASEB J. 23 (2009) 1503-1509